It is known that medical applications using ionising radiation are wide spread and still increasing. Physicians, technicians, nurses and others constitute the largest group of workers occupationally exposed to man-made sources of radiation. Many hospital workers are consequently subjected to routine monitoring of professional radiation exposures. in the university hospital, UZ Brussel, 600 out of 4000 staff members are daily monitored for external radiation exposures. The most obvious applications of ionising radiation are diagnostic radiology, diagnostic or therapeutic use of radionuclides in nuclear medicine and external radiation therapy or brachytherapy in radiotherapy departments. Other important applications also include various procedures in interventional radiology (IR), in vitro biomedical research and radiopharmaceutical production around cyclotrons. Besides the fact that many of the staff members, involved in these applications, are not measurably exposed, detailed studies were carried out at workplaces where routine dose monitoring encounters difficulties and for some applications where relatively high occupational exposures can be found. most of the studies are concentrated around nuclear medicine applications and IR. They contain assessments of both effective dose and doses at different parts of the body. The results contribute to better characterisation of the different workplaces in a way that critical applications can be identified. Moreover, conclusions point out future needs for practical routine dose monitoring and optimisation of radiation protection.
Based on double-dosemeter readings, a conservative effective dose (E) estimation algorithm for lead apron workers in interventional radiology is proposed. Typical radiation conditions for various exposure geometries were simulated using the MCNPX 2.4.0 code. The simulation model consisted of an X-ray source and image intensifier, a patient phantom and a voxelised staff member phantom with lead apron. The effective staff dose and dosemeter readings for several positions of the worker were calculated. The effective dose to a physician, positioned in close proximity to the primary beam, can be estimated within a 10% underestimation margin by E = 1.64 H(p)(10)thorax,under + 0.075 H(p)(10)neck,over. The dose to the eye lens can be estimated by a dosemeter reading at collar level (R2 = 0.98).
In interventional radiology, for an accurate determination of effective dose to the staff, measurements with two dosemeters have been recommended, one located above and one under the protective apron. Such 'double dosimetry' practices and the algorithms used for the determination of effective dose were reviewed in this study by circulating a questionnaire and by an extensive literature search. The results indicated that regulations for double dosimetry almost do not exist and there is no firm consensus on the most suitable calculation algorithms. The calculation of effective dose is mainly based on the single dosemeter measurements, in which either personal dose equivalent, directly, (dosemeter below the apron) or a fraction of personal dose equivalent (dosemeter above the apron) is taken as an assessment of effective dose. The most recent studies suggest that there might not be just one double dosimetry algorithm that would be optimum for all interventional radiology procedures. Further investigations in several critical configurations of interventional radiology procedures are needed to assess the suitability of the proposed algorithms.
The purpose of this study was to determine diagnostic reference levels (DRLs) for common angiographic and interventional procedures in Belgium. Dose Area Product (DAP) measurements were performed on 21 systems, (13 angiography and 4 vascular surgery centres). Type of procedure, total DAP, patient weight and height were collected on a daily basis during 1 y. The 75th percentile of the distribution of DAP values was defined as DRL. Preliminary DRLs were calculated for the three most frequent procedures for the whole population, for a weight class of patients (65-80 kg) and normalised to the standard size patient. Among them, the DRL for angiography of the lower limbs (30% of the procedures) from the whole population was 74.6 and 63.2 Gycm2 for the size corrected. The mean DAP values of each room was then compared to these DRLs.
The purpose of the multi-centre study was to assess dose area product (DAP) and effective dose of patients undergoing angiography of the lower limbs in Belgium and to investigate the correlation between DAP and effective dose. DAP values were measured in 12 centres and compared with the national diagnostic reference levels (DRLs). The effective dose (E) was estimated by multiplying the DAP with case-specific conversion coefficients (CCs) that were calculated with Monte Carlo software MCNP5. As a model for the patient, a mathematical hermaphrodite phantom was used. Calculations showed that tube configurations and extra Cu filtration have a large influence on these CCs. Due to the use of Cu filtration, effective dose can be twice as high for comparable DAP values. Also the use of an over-couch tube configuration is a disadvantage when compared with the under-couch tube configuration. For centres working under-couch without the use of extra Cu-filtration, the DAP values correlate very well with effective dose (Spearman's rank correlation rho ; = 0.97). For these conditions, general CCs between DAP and E were calculated. They were 0.083 mSv Gy(-1) cm(-2) (ICRP 60) and 0.065 mSv Gy(-1) cm(-2) (ICRP 103).
Adolescents and young adults with cystic fibrosis, presenting with only a slight degree of underweight, have at the radius a preserved bone mineral density but a reduced cortical thickness.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.